Literature DB >> 12426336

Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops.

Christopher A Elkins1, Hiroshi Nikaido.   

Abstract

AcrAB-TolC is a constitutively expressed, tripartite efflux transporter complex that functions as the primary resistance mechanism to lipophilic drugs, dyes, detergents, and bile acids in Escherichia coli. TolC is an outer membrane channel, and AcrA is an elongated lipoprotein that is hypothesized to span the periplasm and coordinate efflux of such substrates by AcrB and TolC. AcrD is an efflux transporter of E. coli that provides resistance to aminoglycosides as well as to a limited range of amphiphilic agents, such as bile acids, novobiocin, and fusidic acid. AcrB and AcrD belong to the resistance nodulation division superfamily and share a similar topology, which includes a pair of large periplasmic loops containing more than 300 amino acid residues each. We used this knowledge to test several plasmid-encoded chimeric constructs of acrD and acrB for substrate specificity in a marR1 DeltaacrB DeltaacrD host. AcrD chimeras were constructed in which the large, periplasmic loops between transmembrane domains 1 and 2 and 7 and 8 were replaced with the corresponding loops of AcrB. Such constructs provided resistance to AcrB substrates at levels similar to native AcrB. Conversely, AcrB chimeras containing both loops of AcrD conferred resistance only to the typical substrates of AcrD. These results cannot be explained by simply assuming that AcrD, not hitherto known to interact with AcrA, acquired this ability by the introduction of the loop regions of AcrB, because (i) both AcrD and AcrA were found, in this study, to be required for the efflux of amphiphilic substrates, and (ii) chemical cross-linking in intact cells efficiently produced complexes between AcrD and AcrA. Since AcrD can already interact with AcrA, the alterations in substrate range accompanying the exchange of loop regions can only mean that substrate recognition (and presumably binding) is determined largely by the two periplasmic loops.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12426336      PMCID: PMC135441          DOI: 10.1128/JB.184.23.6490-6499.2002

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  27 in total

Review 1.  The RND permease superfamily: an ancient, ubiquitous and diverse family that includes human disease and development proteins.

Authors:  T T Tseng; K S Gratwick; J Kollman; D Park; D H Nies; A Goffeau; M H Saier
Journal:  J Mol Microbiol Biotechnol       Date:  1999-08

2.  Suppression of hypersensitivity of Escherichia coli acrB mutant to organic solvents by integrational activation of the acrEF operon with the IS1 or IS2 element.

Authors:  K Kobayashi; N Tsukagoshi; R Aono
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

Review 3.  Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria.

Authors:  M H Saier; I T Paulsen; M K Sliwinski; S S Pao; R A Skurray; H Nikaido
Journal:  FASEB J       Date:  1998-03       Impact factor: 5.191

4.  Efflux pumps and drug resistance in gram-negative bacteria.

Authors:  D Ma; D N Cook; J E Hearst; H Nikaido
Journal:  Trends Microbiol       Date:  1994-12       Impact factor: 17.079

5.  Chloramphenicol acetyltransferase may confer resistance to fusidic acid by sequestering the drug.

Authors:  G N Proctor; J McKell; R H Rownd
Journal:  J Bacteriol       Date:  1983-08       Impact factor: 3.490

6.  Analysis of a complete library of putative drug transporter genes in Escherichia coli.

Authors:  K Nishino; A Yamaguchi
Journal:  J Bacteriol       Date:  2001-10       Impact factor: 3.490

7.  Chimeric analysis of the multicomponent multidrug efflux transporters from gram-negative bacteria.

Authors:  Elena B Tikhonova; Quiju Wang; Helen I Zgurskaya
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

8.  Bypassing the periplasm: reconstitution of the AcrAB multidrug efflux pump of Escherichia coli.

Authors:  H I Zgurskaya; H Nikaido
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

9.  Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli.

Authors:  D Ma; D N Cook; M Alberti; N G Pon; H Nikaido; J E Hearst
Journal:  Mol Microbiol       Date:  1995-04       Impact factor: 3.501

10.  Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid-determined efflux of tetracycline.

Authors:  A M George; S B Levy
Journal:  J Bacteriol       Date:  1983-08       Impact factor: 3.490

View more
  113 in total

1.  Comprehensive studies of drug resistance mediated by overexpression of response regulators of two-component signal transduction systems in Escherichia coli.

Authors:  Hidetada Hirakawa; Kunihiko Nishino; Takahiro Hirata; Akihito Yamaguchi
Journal:  J Bacteriol       Date:  2003-03       Impact factor: 3.490

2.  Efflux of cytoplasmically acting antibiotics from gram-negative bacteria: periplasmic substrate capture by multicomponent efflux pumps inferred from their cooperative action with single-component transporters.

Authors:  Michael Palmer
Journal:  J Bacteriol       Date:  2003-09       Impact factor: 3.490

3.  In vivo and in vitro evidence that TtgV is the specific regulator of the TtgGHI multidrug and solvent efflux pump of Pseudomonas putida.

Authors:  Antonia Rojas; Ana Segura; María Eugenia Guazzaroni; Wilson Terán; Ana Hurtado; María Trinidad Gallegos; Juan L Ramos
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

Review 4.  Structure and function of efflux pumps that confer resistance to drugs.

Authors:  M Ines Borges-Walmsley; Kenneth S McKeegan; Adrian R Walmsley
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

5.  Role of histone-like protein H-NS in multidrug resistance of Escherichia coli.

Authors:  Kunihiko Nishino; Akihito Yamaguchi
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

6.  Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop.

Authors:  Thomas Eicher; Hi-jea Cha; Markus A Seeger; Lorenz Brandstätter; Jasmin El-Delik; Jürgen A Bohnert; Winfried V Kern; François Verrey; Markus G Grütter; Kay Diederichs; Klaas M Pos
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

7.  Bile-mediated aminoglycoside sensitivity in Lactobacillus species likely results from increased membrane permeability attributable to cholic acid.

Authors:  Christopher A Elkins; Lisa B Mullis
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

Review 8.  Multidrug resistance in bacteria.

Authors:  Hiroshi Nikaido
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

9.  Aminoglycosides are captured from both periplasm and cytoplasm by the AcrD multidrug efflux transporter of Escherichia coli.

Authors:  Julio Ramos Aires; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

10.  β-Lactam selectivity of multidrug transporters AcrB and AcrD resides in the proximal binding pocket.

Authors:  Naoki Kobayashi; Norihisa Tamura; Hendrik W van Veen; Akihito Yamaguchi; Satoshi Murakami
Journal:  J Biol Chem       Date:  2014-02-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.